Patriot Financial Group Insurance Agency’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-390
Closed -$37K 880
2022
Q2
$37K Sell
390
-34
-8% -$3.52K 0.01% 823
2022
Q1
$50K Sell
424
-74
-15% -$8.3K 0.01% 774
2021
Q4
$65K Buy
498
+58
+13% +$6.76K 0.01% 775
2021
Q3
$50K Hold
440
0.01% 867
2021
Q2
$46K Buy
440
+105
+31% +$9.9K 0.01% 858
2021
Q1
$28K Buy
335
+85
+34% +$7.19K 0.01% 968
2020
Q4
$23K Hold
250
0.01% 923
2020
Q3
$20K Buy
250
+90
+56% +$7.02K 0.01% 791
2020
Q2
$11K Buy
+160
New +$11.4K ﹤0.01% 937
2018
Q2
Sell
-30
Closed -$1K 682
2018
Q1
$1K Hold
30
﹤0.01% 906
2017
Q4
$1K Hold
30
﹤0.01% 889
2017
Q3
$1K Buy
30
+9
+43% +$343 ﹤0.01% 873
2017
Q2
$1K Buy
+21
New +$767 ﹤0.01% 870

Other funds holding EW

Patriot Financial Group Insurance Agency's EW Position: Q3 2022 in Review

Patriot Financial Group Insurance Agency sold out of Edwards Lifesciences (EW) in Q3 2022, closing a stake of 390 shares — an estimated $37K sold.

Patriot Financial Group Insurance Agency first reported a position in EW in Q2 2017 and held it in 13 quarters. The position peaked at $65K in Q4 2021. 1,247 funds tracked by Wall St. Rank hold EW as of Q3 2022.

  • Patriot Financial Group Insurance Agency reported no remaining Edwards Lifesciences position as of Q3 2022 after selling out during the quarter.
  • Patriot Financial Group Insurance Agency sold 390 Edwards Lifesciences shares in Q3 2022, an estimated $37K.
  • Patriot Financial Group Insurance Agency first reported a position in Edwards Lifesciences in Q2 2017 and held it in 13 quarters.
  • Patriot Financial Group Insurance Agency's Edwards Lifesciences position peaked at $65K in Q4 2021.
  • 1,247 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2022.

Based on Patriot Financial Group Insurance Agency's 13F filing for Q3 2022, filed 1 Nov 2022.